Anti-Reflux Band Mucosectomy (ARBM)

About Endolastic

Endolastic is a private, pre-revenue medical device company advancing its EndoBand™ platform for endoscopic, band-based interventions. With over 50 successful human cases using its first-generation device, the company is preparing for commercial launch and regulatory filings, supported by a $4M physician-led seed round. Its technology aims to offer a durable, anatomical solution for GERD, obesity, and diabetes, positioned between pharmaceutical therapies and invasive surgery in terms of efficacy, cost, and procedural simplicity.

Therapeutic Areas

Other Gastroesophageal Reflux Disease (GERD) Drugs